Literature DB >> 1575745

Mechanism of inhibition of cholinesterases by huperzine A.

Y Ashani1, J O Peggins, B P Doctor.   

Abstract

Huperzine A, an alkaloid isolated from Huperzia serrata was found to reversibly inhibit acetylcholinesterases (EC 3.1.1.7) and butyrylcholinesterases (EC 3.1.1.8) with on- and off-rates that depend on both the type and the source of enzyme. Long-term incubation of high concentrations of purified cholinesterases (1-8 microM) with huperzine A did not show any chemical modification of huperzine A. A low dissociation constant KI was obtained for mammalian acetylcholinesterase-huperzine (20-40 nM) compared to mammalian butyrylcholinesterase-huperzine (20-40 microM). This indicates that the thermodynamic stability of huperzine-cholinesterase complex may depend on the number and type of aromatic amino acid residues in the catalytic pocket region of the cholinesterase molecule.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1575745     DOI: 10.1016/0006-291x(92)90649-6

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

1.  Enantiomer effects of huperzine A on the aryl acylamidase activity of human cholinesterases.

Authors:  Sultan Darvesh; Ryan Walsh; Earl Martin
Journal:  Cell Mol Neurobiol       Date:  2003-02       Impact factor: 5.046

2.  A computational model of the nicotinic acetylcholine binding site.

Authors:  E Gálvez-Ruano; I Iriepa-Canalda; A Morreale; K B Lipkowitz
Journal:  J Comput Aided Mol Des       Date:  1999-01       Impact factor: 3.686

3.  [+]-Huperzine A protects against soman toxicity in guinea pigs.

Authors:  Ying Wang; Yanling Wei; Samuel Oguntayo; Neil Jensen; Bhupendra P Doctor; Madhusoodana P Nambiar
Journal:  Neurochem Res       Date:  2011-08-07       Impact factor: 3.996

4.  Time Course, Behavioral Safety, and Protective Efficacy of Centrally Active Reversible Acetylcholinesterase Inhibitors in Cynomolgus Macaques.

Authors:  Lindsey R Hamilton; Steven C Schachter; Todd M Myers
Journal:  Neurochem Res       Date:  2016-11-30       Impact factor: 3.996

5.  Acetylcholinesterase plays a non-neuronal, non-esterase role in organogenesis.

Authors:  Melissa A Pickett; Michael K Dush; Nanette M Nascone-Yoder
Journal:  Development       Date:  2017-07-06       Impact factor: 6.868

6.  A phase II trial of huperzine A in mild to moderate Alzheimer disease.

Authors:  M S Rafii; S Walsh; J T Little; K Behan; B Reynolds; C Ward; S Jin; R Thomas; P S Aisen
Journal:  Neurology       Date:  2011-04-19       Impact factor: 9.910

7.  The combination of huperzine A and imidazenil is an effective strategy to prevent diisopropyl fluorophosphate toxicity in mice.

Authors:  Fabio Pibiri; Alan P Kozikowski; Graziano Pinna; James Auta; Bashkim Kadriu; Erminio Costa; Alessandro Guidotti
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-10       Impact factor: 11.205

Review 8.  Non-cholinergic effects of huperzine A: beyond inhibition of acetylcholinesterase.

Authors:  Hai Yan Zhang; Han Yan; Xi Can Tang
Journal:  Cell Mol Neurobiol       Date:  2007-07-27       Impact factor: 5.046

9.  Identification of amino acid residues involved in the binding of Huperzine A to cholinesterases.

Authors:  A Saxena; N Qian; I M Kovach; A P Kozikowski; Y P Pang; D C Vellom; Z Radić; D Quinn; P Taylor; B P Doctor
Journal:  Protein Sci       Date:  1994-10       Impact factor: 6.725

10.  Prediction of the binding sites of huperzine A in acetylcholinesterase by docking studies.

Authors:  Y P Pang; A P Kozikowski
Journal:  J Comput Aided Mol Des       Date:  1994-12       Impact factor: 3.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.